Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Original versus generic moxifloxacin 0.5% ophthalmic solution in cataract surgery patients
TCTR20261102004Phase 3Completed
- Sponsor
- Siam Pharmaceutical
- Start
- Jun 2019
- Modality
- Orthosteric Ligands → Classical Binding Small Molecules → Small Molecules, Covalent Small Molecules → Small Molecules, Nucleic Acid-Directed Small Molecules → Small Molecules
- Countries
- 1
01
Overview
A Phase 3 trial of moxifloxacin, sponsored by Siam Pharmaceutical. Started Jun 2019; status: completed.
02
Drugs
moxifloxacin
Beyond the preview
Go deeper on TCTR20261102004.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on TCTR20261102004.